Pharmacokinetics and pharmacodynamics of macimorelin acetate (EZS-130) in paediatric patients with suspected growth hormone deficiency (GHD)

dc.contributor.authorCsákváry, V.
dc.contributor.authorMuzsnai, A.
dc.contributor.authorRaduk, D.
dc.contributor.authorChaychenko, Tetyana
dc.contributor.authorDamholt, B.
dc.contributor.authorBagci, E.
dc.contributor.authorTeifel, M.
dc.contributor.authorAmmer, N.
dc.date.accessioned2020-12-03T19:28:56Z
dc.date.available2020-12-03T19:28:56Z
dc.date.issued2020
dc.identifier.citationPharmacokinetics and pharmacodynamics of macimorelin acetate (AEZS-130) in paediatric patients with suspected growth hormone deficiency (GHD) / V. Csákváry, A. Muzsnai, D. Raduk, T. Chaychenko, B. B. Damholt, E. B. Bagci, M. Teifel, N. Ammer // Endocrine Abstracts. – 2020. – Volume 70 : Тhe 22nd European Congress оf Endocrinology E-ECE 2020, September 5–9, 2020. – DOI: 10.1530/endoabs.70.AEP1064.en_US
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/27817
dc.language.isoenen_US
dc.titlePharmacokinetics and pharmacodynamics of macimorelin acetate (EZS-130) in paediatric patients with suspected growth hormone deficiency (GHD)en_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Фармакокинетика и фармакодинамика мациморелин ацетат у детей с дефицитом гормона роста.pdf
Size:
79.31 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
11.22 KB
Format:
Item-specific license agreed upon to submission
Description: